| Date Filed | Type | Description |
| 10/06/2023 |
4/A
| HENRY CHRISTIAN O (Director) has filed a Form 4 on Ginkgo Bioworks Holdings, Inc.|
Txns:
| Sold 4,499 shares
@ $1.78, valued at
$8k
|
|
| 10/04/2023 |
4
| HENRY CHRISTIAN O (Director) has filed a Form 4 on Ginkgo Bioworks Holdings, Inc.|
Txns:
| Sold 4,499 shares
@ $4499, valued at
$20.2M
|
|
| 10/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/09/2023 |
4
| HENRY CHRISTIAN O (Director) has filed a Form 4 on Wave Life Sciences Ltd.|
Txns:
| Granted 45,000 options to buy
@ $4.58, valued at
$206.1k
|
|
| 08/04/2023 |
4
| HENRY CHRISTIAN O (Director) has filed a Form 4 on Ginkgo Bioworks Holdings, Inc.|
Txns:
| Sold 4,499 shares
@ $2.25, valued at
$10.1k
|
|
| 08/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/06/2023 |
4
| HENRY CHRISTIAN O (Director) has filed a Form 4 on Ginkgo Bioworks Holdings, Inc.|
Txns:
| Sold 4,499 shares
@ $1.89, valued at
$8.5k
|
|
| 07/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/12/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/06/2023 |
4
| HENRY CHRISTIAN O (Director) has filed a Form 4 on Ginkgo Bioworks Holdings, Inc.|
Txns:
| Sold 4,499 shares
@ $1.63, valued at
$7.3k
|
|
| 06/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/04/2023 |
4
| HENRY CHRISTIAN O (Director) has filed a Form 4 on Ginkgo Bioworks Holdings, Inc.|
Txns:
| Sold 4,499 shares
@ $1.16, valued at
$5.2k
|
|
| 05/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/05/2023 |
4
| HENRY CHRISTIAN O (Director) has filed a Form 4 on Ginkgo Bioworks Holdings, Inc.|
Txns:
| Sold 4,499 shares
@ $1.32, valued at
$5.9k
|
|
| 04/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/16/2023 |
4
| HENRY CHRISTIAN O (Director) has filed a Form 4 on Ginkgo Bioworks Holdings, Inc.|
Txns:
| Sold 4,499 shares
@ $1.37, valued at
$6.2k
|
|
| 03/06/2023 |
4
| HENRY CHRISTIAN O (See Remarks) has filed a Form 4 on PACIFIC BIOSCIENCES OF CALIFORNIA, INC.|
Txns:
| Granted 594,687 shares
@ $0
Sold 13,769 shares
@ $9.493, valued at
$130.7k
|
|
| 02/22/2023 |
4
| HENRY CHRISTIAN O (See Remarks) has filed a Form 4 on PACIFIC BIOSCIENCES OF CALIFORNIA, INC.|
Txns:
| Sold 1,530 shares
@ $10.271, valued at
$15.7k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2023 |
4
| HENRY CHRISTIAN O (Director) has filed a Form 4 on Ginkgo Bioworks Holdings, Inc.|
Txns:
| Sold 4,499 shares
@ $1.57, valued at
$7.1k
|
|
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/19/2022 |
4
| HENRY CHRISTIAN O (See Remarks) has filed a Form 4 on PACIFIC BIOSCIENCES OF CALIFORNIA, INC.|
Txns:
| Sold 91,307 shares
@ $5.7765, valued at
$527.4k
|
|
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/14/2022 |
4
| HENRY CHRISTIAN O (Director) has filed a Form 4 on Ginkgo Bioworks Holdings, Inc.|
Txns:
| Granted 1,071,395 shares
@ $0 |
|
| 03/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/20/2021 |
4
| HENRY CHRISTIAN O (Director) has filed a Form 4 on Ginkgo Bioworks Holdings, Inc.|
Txns:
| Granted 234,548 shares
@ $0 |
|
| 09/20/2021 |
4/A
| HENRY CHRISTIAN O (President & CEO) has filed a Form 4 on PACIFIC BIOSCIENCES OF CALIFORNIA, INC.|
Txns:
| Sold 90,520 shares
@ $26.91, valued at
$2.4M
|
|
| 09/20/2021 |
3
| HENRY CHRISTIAN O (Director) has filed a Form 3 on Ginkgo Bioworks Holdings, Inc. |
|